Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma is more effective and satisfactory than hyaluronic acid for knee osteoarthritis.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Minoxidil was first made for high blood pressure, but it was later found to help hair growth.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Getting the right amount of selenium is important for health; too little can cause disease, and too much can lead to toxicity.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Androgen use may increase the risk of stroke, but more research is needed.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

PRP improves hair growth in androgenic alopecia, especially when combined with minoxidil.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Non-laser devices show promise in treating hair issues, but more research is needed.

Blue light therapy is promising for skin and hair conditions but needs more research for widespread use.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

3D bioprinting shows promise for creating advanced skin for healing wounds and reducing animal testing.